Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
(NASDAQ: FRNM) Delayed: 16.60 -0.51 (2.98%)
Previous Close $17.11    52 Week High $ 
Open $17.19    52 Week Low $ 
Day High $17.50    P/E N/A 
Day Low $16.60    EPS $ 
Volume 588,229